4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-18-018333
Chief Scientific Officer acquired 4,370 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| COOKE MICHAEL P. Chief Scientific Officer | 2018-06-25 | Conversion | +4,370 | 293,023 | D | ||
| Derivatives | |||||||
| COOKE MICHAEL P. Chief Scientific Officer | 2018-06-25 | Conversion · Series A Preferred Stock | −10,005 | 0 | D | ||
| COOKE MICHAEL P. Chief Scientific Officer | 2018-06-25 | Conversion · Series B Preferred Stock | −1,287 | 0 | D | ||
Loading xslF345X03/doc4.xml…